Related Experiment Videos
Mineral changes in a transgenic mouse model for osteogenesis imperfecta
J P Cassella1, R Pereira, D J Prockop
1Department of Experimental Pathology, University of London, Stanmore, England, UK.
British Journal of Biomedical Science
|June 1, 1996
Summary
Transgenic mice with a defective collagen gene exhibit brittle bones and lower calcium-to-phosphorus ratios, similar to human osteogenesis imperfecta (brittle bone disease). This model aids in understanding fragile bone conditions.
Area of Science:
- Biochemistry
- Genetics
- Orthopedics
Background:
- Osteogenesis imperfecta (OI) is a genetic disorder characterized by brittle bones.
- Previous studies reported fractures and reduced bone quality in transgenic mice expressing a defective human procollagen gene.
Purpose of the Study:
- To evaluate a transgenic mouse model for its suitability in studying osteogenesis imperfecta.
- To compare bone mineral composition and structural integrity between transgenic mice and normal littermates.
Main Methods:
- Investigated transgenic mice expressing an internally deleted human pro-alpha 1(I) collagen gene.
- Utilized X-ray microanalysis to determine bone mineral composition (calcium to phosphorus ratio).
- Employed Fourier-transform infra-red spectroscopy to analyze mineral structure and performed biomechanical assessments.
Main Results:
- Transgenic mice displayed a lower calcium to phosphorus molar ratio in bone mineral compared to normal littermates.
- Ultrastructural mineral changes in transgenic mice were comparable to those in human OI patients.
- Multiple fracture calluses were observed in transgenic mice, indicating increased bone fragility.
Conclusions:
- The transgenic mouse model exhibits key characteristics of osteogenesis imperfecta, including altered bone mineral composition and fragility.
- This model provides a valuable tool for investigating the pathology of brittle bone disease.
- Further research using this model may enhance understanding and treatment strategies for OI.